Clinical Trials Directory

Trials / Completed

CompletedNCT05184387

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness in an Urban and Suburban Population of Healthy Subjects Aged 18-55 Years, Not Vaccinated Against Influenza.

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Osivax · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This Prospective epidemiological cohort study is being conducted in order to generate epidemiological data in support of Osivax's clinical development of a broad spectrum influenza vaccine based upon the internal influenza nucleoprotein (NP) as a target for immune response.

Detailed description

The present study is being conducted in order to generate epidemiological data in support of Osivax's clinical development of a broad spectrum influenza vaccine based upon the internal influenza nucleoprotein (NP) as a target for immune response.

Conditions

Interventions

TypeNameDescription
OTHERBlood samplesCollection of blood samples and completion of an electronic Diary (eDiary)

Timeline

Start date
2021-12-01
Primary completion
2022-07-12
Completion
2022-07-12
First posted
2022-01-11
Last updated
2022-07-19

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05184387. Inclusion in this directory is not an endorsement.

A Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness. (NCT05184387) · Clinical Trials Directory